» Articles » PMID: 28397131

Making a Medical Home for IBD Patients

Overview
Specialty Gastroenterology
Date 2017 Apr 12
PMID 28397131
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: The transformation from fee for service to fee for value requires structural changes to the way gastroenterologists manage patients with inflammatory bowel disease (IBD). A team-based approach using technology to engage patients is necessary for success. The Patient-Centered Medical Home (PCMH) represents a unique model that brings together these essential features. This paper describes how the PCMH model has been successfully applied to the management of patients with IBD.

Recent Findings: A review of the literature and three examples of IBD PCMH initiatives are presented in this document: they demonstrate how outcomes can be improved under the PCMH model. Population health and value-based payments will mold and shape how we can position our GI practices. The specialty medical home is an ideal way to begin this transition.

Citing Articles

Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.

Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S Inflamm Bowel Dis. 2024; 31(1):77-86.

PMID: 38507608 PMC: 11700895. DOI: 10.1093/ibd/izae040.


Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center.

Choi D, Rubin D, Puangampai A, Lach M Crohns Colitis 360. 2023; 5(2):otad018.

PMID: 37082614 PMC: 10111283. DOI: 10.1093/crocol/otad018.


Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians.

Bhat S Crohns Colitis 360. 2023; 5(2):otad014.

PMID: 36937137 PMC: 10022714. DOI: 10.1093/crocol/otad014.


The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review.

Volpato E, Bosio C, Previtali E, Leone S, Armuzzi A, Pagnini F BMC Gastroenterol. 2021; 21(1):293.

PMID: 34261434 PMC: 8278693. DOI: 10.1186/s12876-021-01850-1.


Integrated Care Models: Optimizing Adult Ambulatory Care in Inflammatory Bowel Disease.

Schoenfeld R, Nguyen G, Bernstein C J Can Assoc Gastroenterol. 2021; 3(1):44-53.

PMID: 34169226 PMC: 8218536. DOI: 10.1093/jcag/gwy060.


References
1.
Hommes D, Colombel J, Emery P, Greco M, Sandborn W . Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis. 2012; 6 Suppl 2:S224-34. DOI: 10.1016/S1873-9946(12)60502-9. View

2.
Rubin D . Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon?. Inflamm Bowel Dis. 2016; 22(8):1981-3. DOI: 10.1097/MIB.0000000000000813. View

3.
Pines J, Keyes V, van Hasselt M, McCall N . Emergency department and inpatient hospital use by Medicare beneficiaries in patient-centered medical homes. Ann Emerg Med. 2015; 65(6):652-60. DOI: 10.1016/j.annemergmed.2015.01.002. View

4.
Loftus Jr E . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. DOI: 10.1053/j.gastro.2004.01.063. View

5.
Irvine E, Feagan B, Rochon J, Archambault A, Fedorak R, Groll A . Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994; 106(2):287-96. DOI: 10.1016/0016-5085(94)90585-1. View